Takeda Pharmaceutical (TAK) Beginning Cash Balance (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Beginning Cash Balance of $3.7 billion for Q2 2026, up 40.27% year-over-year from $2.7 billion in Q2 2025, and up 40.27% quarter-over-quarter from $2.7 billion in Q2 2025.
Takeda Pharmaceutical (TAK) Beginning Cash Balance (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Beginning Cash Balance history runs 9 years deep, the most recent figure standing at $3.7 billion for Q2 2026.
- In Q2 2026, Beginning Cash Balance rose 40.27% year-over-year to $3.7 billion; the TTM figure through Jun 2026 stood at $3.7 billion (up 40.27% YoY), while the FY2026 annual figure was $2.6 billion, down 14.87% from the prior year.
- Beginning Cash Balance for Q2 2026 stood at $3.7 billion, up from $2.7 billion in the prior quarter.
- The five-year high for Beginning Cash Balance was $6.6 billion in Q2 2022, with the low at $2.7 billion in Q2 2025.
- The 5-year median for Beginning Cash Balance is $3.7 billion (2026), against an average of $4.0 billion.
- The sharpest annual moves came in 2023 and 2026: Beginning Cash Balance tumbled 40.75% in 2023, then surged 40.27% in 2026.
- Takeda Pharmaceutical's Beginning Cash Balance stood at $6.6 billion in 2022, then slumped by 40.75% to $3.9 billion in 2023, then declined by 24.46% to $2.9 billion in 2024, then dropped by 9.5% to $2.7 billion in 2025, then soared by 40.27% to $3.7 billion in 2026.
- Business Quant data shows TAK's Beginning Cash Balance at $3.7 billion in Q2 2026, $2.7 billion in Q2 2025, and $2.9 billion in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.73 Bn |
| Jun 30, 2026 | 3.73 Bn |
| Jun 30, 2025 | 2.66 Bn |
| Jun 30, 2025 | 2.66 Bn |
| Jun 30, 2024 | 2.94 Bn |
| Jun 30, 2024 | 2.94 Bn |
| Jun 30, 2023 | 3.89 Bn |
| Jun 30, 2023 | 3.89 Bn |
| Jun 30, 2022 | 6.57 Bn |
| Jun 30, 2022 | 6.57 Bn |
| Jun 30, 2021 | 8.83 Bn |
| Jun 30, 2021 | 8.83 Bn |
| Jun 30, 2020 | 5.93 Bn |
| Jun 30, 2020 | 5.93 Bn |
| Jun 30, 2019 | 6.39 Bn |
| Jun 30, 2019 | 6.39 Bn |
| Mar 31, 2019 | 6.38 Bn |
| Mar 31, 2019 | 6.38 Bn |
| Jun 30, 2018 | 2.71 Bn |
| Jun 30, 2018 | 2.71 Bn |